↓ Skip to main content

Response to pioglitazone in non-alcoholic fatty liver disease patients with vs. without type 2 diabetes: A meta-analysis of randomized controlled trials

Overview of attention for article published in Frontiers in endocrinology, March 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Response to pioglitazone in non-alcoholic fatty liver disease patients with vs. without type 2 diabetes: A meta-analysis of randomized controlled trials
Published in
Frontiers in endocrinology, March 2023
DOI 10.3389/fendo.2023.1111430
Pubmed ID
Authors

Zeyu Wang, Huiqing Du, Ying Zhao, Yadi Ren, Cuihua Ma, Hongyu Chen, Man Li, Jiageng Tian, Caihong Xue, Guangfeng Long, Meidong Xu, Yong Jiang

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 31 100%

Demographic breakdown

Readers by professional status Count As %
Other 6 19%
Student > Bachelor 3 10%
Researcher 1 3%
Lecturer > Senior Lecturer 1 3%
Student > Master 1 3%
Other 2 6%
Unknown 17 55%
Readers by discipline Count As %
Medicine and Dentistry 10 32%
Agricultural and Biological Sciences 3 10%
Arts and Humanities 1 3%
Biochemistry, Genetics and Molecular Biology 1 3%
Unknown 16 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 March 2023.
All research outputs
#20,597,484
of 26,171,302 outputs
Outputs from Frontiers in endocrinology
#6,008
of 13,375 outputs
Outputs of similar age
#305,916
of 429,088 outputs
Outputs of similar age from Frontiers in endocrinology
#339
of 844 outputs
Altmetric has tracked 26,171,302 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,375 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 429,088 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 844 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.